BUZZ-巴克莱因收购 Exact Sciences 上调雅培目标价

路透中文
Apr 08
BUZZ-巴克莱因收购 Exact Sciences 上调<a href="https://laohu8.com/S/ABT">雅培</a>目标价

4月8日 - ** 巴克莱银行将医疗设备制造商雅培实验室ABT.N的**目标价**从142美元上调至144美元

** 重申 "增持 "评级

** 巴克莱称其更新了模型,以反映雅培对Exact Sciences (link) 的收购,上调了收入预期,同时考虑到了近期的盈利稀释。

** 新目标价较上一交易日收盘价上涨 41.4**%**

** 券商将2026年销售额预期上调了约6%,与管理层的展望一致,但由于交易相关的摊薄,每股收益预期下调了约4%。

** 巴克莱预计,Exact 的收购在 2026 年和 2027 年会有适度的摊薄作用,但从长期来看,盈利将转为增益性

** 31家券商中有23家将该股评级定为 "买入 "或更高,8家为 "持有";根据LSEG汇编的数据,他们的**目标价**中值为134.4美元。

** 截至上次收盘,该股**今年迄今下跌** 18.7**%**

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10